businesswire.com

Reputation Factor: 3.96 High
Sites Owned: 2
Total Reference Links: 300
Total Citations: 361
Unique Wikipedia Articles Citing: 262

Associated Sites

secure.businesswire.com

Uncategorized

Links: 3

Citations: 4

www.businesswire.com

News

Links: 297

Citations: 357

Top Reference Links

Score	Article	Site	Category	Cited In (Articles)
27.7	Porter Introduces 4 New Winter Destinations for 2026-27 Season, Increases Sun Capacity by Greater Than 150% https://www.businesswire.com/news/home/20260430131474/en/Porter-Introduces-4-New-Winter-Destinations-for-2026-27-Season-Increases-Sun-Capacity-by-Greater-Than-150	www.businesswire.com	News	7
23.8	Porter Airlines Welcomes the Sun With Service to Mexico, the Caribbean and Costa Rica https://www.businesswire.com/news/home/20250624131083/en/Porter-Airlines-Welcomes-the-Sun-With-Service-to-Mexico-the-Caribbean-and-Costa-Rica	www.businesswire.com	News	6
11.9	First Brands Group Commences Wind Down of North American Brake Parts Inc., Cardone, and Autolite Business Units https://www.businesswire.com/news/home/20260126446855/en/First-Brands-Group-Commences-Wind-Down-of-North-American-Brake-Parts-Inc.-Cardone-and-Autolite-Business-Units	www.businesswire.com	News	3
11.9	Vivendi: Results for the First Half of 2025 https://www.businesswire.com/news/home/20250731972377/en/Vivendi-Results-for-the-First-Half-of-2025	www.businesswire.com	News	3
11.9	Madonna, Shakira, and BTS to Co-Headline the First-Ever FIFA World Cup™ Final Halftime Show https://www.businesswire.com/news/home/20260514891433/en/Madonna-Shakira-and-BTS-to-Co-Headline-the-First-Ever-FIFA-World-Cup-Final-Halftime-Show	www.businesswire.com	News	3
7.9	KalVista Pharmaceuticals Announces FDA Approval of Ekterly (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema https://www.businesswire.com/news/home/20250702871458/en/KalVista-Pharmaceuticals-Announces-FDA-Approval-of-EKTERLY-sebetralstat-First-and-Only-Oral-On-demand-Treatment-for-Hereditary-Angioedema	www.businesswire.com	News	2
7.9	Yeztugo (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection https://www.businesswire.com/news/home/20250520465880/en/Yeztugo-Lenacapavir-Is-Now-the-First-and-Only-FDA-Approved-HIV-Prevention-Option-Offering-6-Months-of-Protection	www.businesswire.com	News	2
7.9	Scholar Rock Announces FDA Approval of Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA) https://www.businesswire.com/news/home/20260911564629/en/Scholar-Rock-Announces-FDA-Approval-of-ISEMBYLD-apitegromab-mstn-the-First-and-Only-Muscle-Targeted-Treatment-for-Children-and-Adults-with-Spinal-Muscular-Atrophy-SMA	www.businesswire.com	News	2
7.9	Dawnzera (donidalorsen) approved in the U.S. as first and only RNA-targeted prophylactic treatment for hereditary angioedema https://www.businesswire.com/news/home/20250818615141/en/DAWNZERA-donidalorsen-approved-in-the-U.S.-as-first-and-only-RNA-targeted-prophylactic-treatment-for-hereditary-angioedema	www.businesswire.com	News	2
7.9	Porter Airlines increases sun destination capacity up to 25% and launches four new winter routes https://www.businesswire.com/news/home/20251001567458/en/Porter-Airlines-increases-sun-destination-capacity-up-to-25-and-launches-four-new-winter-routes	www.businesswire.com	News	2

Citation Trends Over Time